CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 240 enrolled
Drug / intervention
Clotrimazole vaginal tablet +1 moredrug
Likely dose
Clotrimazole vaginal tablet 500 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02180828
NCT02180828Phase 4Completed
CompareCT.gov

An Case-controlled Randomized Study to the Efficacy of Clotrimazole Vaginal Tablet vs Fluconazole for Severe Vulvovaginal Candidiasis

Peking University Shenzhen Hospital·interventional·Posted Jul 3, 2014·Updated May 2, 2017

In Brief

A Phase 4 clinical trial evaluating Clotrimazole vaginal tablet and Fluconazole for Candidiasis, Vulvovaginal. Completed, enrolled 240 participants across 1 site.

Detailed Summary

The study is focused to prove that the efficacy and safety of Clotrimazole vaginal tablet vs Fluconazole for the treatment of severe vulvovaginal candidiasis

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCandidiasis, Vulvovaginal
CountriesChina
CollaboratorsBayer

Timeline

Phase 4CompletedFinished
201520162017201820192020202120222023202420252026
First PostedJul 3, 2014
Enrollment StartJul 1, 2014
Primary CompletionSep 1, 2015
TodayJul 2, 2026
Enrollment to primary: 1.2 yearsPosted 12.0 years ago

Interventions

Clotrimazole vaginal tabletdrug

2 doses of 500 mg Clotrimazole administered intravaginally (at day1 and day4)

Fluconazoledrug

2 doses of 150 mg oral Fluconazole (at day1 and day4)